Barclays PLC Pulse Biosciences, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Barclays PLC holds 30,306 shares of PLSE stock, worth $546,114. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,306

Previous 30,306 -0.0%

Holding current value

$546,114

Previous $530,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$10.83 - $21.83 $257,082 - $518,200	23,738 Added 361.42%	30,306 $530,000
Q2 2024 Aug 14, 2024	SELL	$6.69 - $14.54 $31,817 - $69,152	-4,756 Reduced 42.0%	6,568 $74,000
Q1 2024 May 15, 2024	SELL	$7.8 - $11.02 $84,661 - $119,611	-10,854 Reduced 48.94%	11,324 $99,000
Q4 2023 Feb 15, 2024	BUY	$3.85 - $12.84 $73,869 - $246,361	19,187 Added 641.49%	22,178 $271,000
Q3 2023 Nov 07, 2023	SELL	$4.03 - $8.73 $999 - $2,165	-248 Reduced 7.66%	2,991 $11,000
Q2 2023 Aug 03, 2023	BUY	$3.67 - $8.64 $11,193 - $26,352	3,050 Added 1613.76%	3,239 $23,000
Q1 2023 May 04, 2023	SELL	$2.48 - $3.88 $29 - $46	-12 Reduced 5.97%	189 $1,000
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.89 $27 - $46	-16 Reduced 7.37%	201 $1,000
Q3 2022 Nov 03, 2022	SELL	$1.23 - $2.3 $290 - $542	-236 Reduced 52.1%	217 $0
Q2 2022 Aug 12, 2022	SELL	$1.48 - $4.28 $2,672 - $7,729	-1,806 Reduced 79.95%	453 $1,000
Q1 2022 May 16, 2022	SELL	$4.21 - $14.79 $61,588 - $216,362	-14,629 Reduced 86.62%	2,259 $11,000
Q4 2021 Feb 14, 2022	BUY	$14.78 - $24.4 $165,565 - $273,328	11,202 Added 197.01%	16,888 $251,000
Q3 2021 Nov 09, 2021	BUY	$17.25 - $26.63 $65,877 - $101,699	3,819 Added 204.55%	5,686 $123,000
Q2 2021 Aug 13, 2021	SELL	$16.31 - $23.64 $163,148 - $236,470	-10,003 Reduced 84.27%	1,867 $31,000
Q1 2021 May 13, 2021	BUY	$22.43 - $44.27 $167,058 - $329,722	7,448 Added 168.43%	11,870 $282,000
Q4 2020 Feb 11, 2021	SELL	$11.66 - $24.5 $22,480 - $47,236	-1,928 Reduced 30.36%	4,422 $105,000
Q3 2020 Nov 12, 2020	SELL	$9.27 - $13.14 $11,596 - $16,438	-1,251 Reduced 16.46%	6,350 $75,000
Q2 2020 Aug 12, 2020	BUY	$6.23 - $13.09 $24,010 - $50,448	3,854 Added 102.86%	7,601 $79,000
Q1 2020 May 13, 2020	SELL	$5.23 - $15.2 $39,235 - $114,030	-7,502 Reduced 66.69%	3,747 $27,000
Q4 2019 Feb 10, 2020	BUY	$12.58 - $15.97 $71,190 - $90,374	5,659 Added 101.23%	11,249 $151,000
Q3 2019 Nov 14, 2019	SELL	$10.73 - $17.33 $17,790 - $28,733	-1,658 Reduced 22.88%	5,590 $87,000
Q2 2019 Aug 14, 2019	BUY	$11.11 - $17.34 $46,462 - $72,515	4,182 Added 136.4%	7,248 $96,000
Q1 2019 May 15, 2019	BUY	$11.69 - $19.44 $35,537 - $59,097	3,040 Added 11692.31%	3,066 $54,000
Q4 2018 Feb 14, 2019	SELL	$9.08 - $14.34 $40,070 - $63,282	-4,413 Reduced 99.41%	26 $0
Q3 2018 Nov 14, 2018	BUY	$12.83 - $16.45 $46,701 - $59,878	3,640 Added 455.57%	4,439 $63,000
Q2 2018 Aug 14, 2018	SELL	$14.04 - $20.28 $15,752 - $22,754	-1,122 Reduced 58.41%	799 $12,000
Q1 2018 May 15, 2018	BUY	$12.67 - $24.69 $5,739 - $11,184	453 Added 30.86%	1,921 $25,000
Q4 2017 Feb 14, 2018	SELL	$18.81 - $30.33 $113,255 - $182,616	-6,021 Reduced 80.4%	1,468 $35,000
Q3 2017 Nov 14, 2017	BUY	$10.26 - $24.97 $76,837 - $187,000	7,489	7,489 $139,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

5.41M

Call Options Held

139K

Put Options Held

84.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $669M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account